Used in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds, particularly those targeting enzyme inhibition and anti-inflammatory agents. Shows potential in the development of kinase inhibitors due to its structural affinity for ATP-binding sites. Also investigated for antiproliferative activity in cancer cell lines, making it valuable in oncology-related drug discovery. Its benzimidazole core contributes to DNA interaction properties, supporting applications in antimicrobial and antiviral studies. Employed in the design of small-molecule therapeutics with enhanced binding selectivity and metabolic stability.